OphthaNova Therapeutics AG

History from 19 Aug 2025

Nominal capital · CHFCHF 112k

SHAB published 22 Aug 2025 · legal date 19 Aug 2025
Company formed
Founded 19 Aug 2025
SHAB HR01-1006414141 ↗
SHAB published 4 Jun 2026 · legal date 21 May 2026
Capital increase
Likely financing
Paid in cash
Nominal capital
100’000 → 111’525.40
Shares
100’000 → 1’115’254
New shares, % of post-step shares
— (nominal value per share changed)
Aktienkapital neu: CHF 111'525.40 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 111'525.40 [bisher: CHF 100'000.00]. Aktien neu: 1'115'254 Namenaktien zu CHF 0.10 [bisher: 100'000 Namenaktien zu CHF 1.00].
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company was founded less than six years before this capital increase.+0.5
Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006666975 ↗

Published by 7 Jun 2026

Record